Literature DB >> 28058965

Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.

Jin Myoung Seok1, Hye-Jin Cho2, Suk-Won Ahn3, Eun Bin Cho4, Min Su Park5, In-Soo Joo6, Ha Young Shin7, Sun-Young Kim8, Byung-Jo Kim9, Jong Kuk Kim10, Joong-Yang Cho11, So-Young Huh12, Ohyun Kwon13, Kwang-Ho Lee1, Byoung Joon Kim1, Ju-Hong Min1.   

Abstract

BACKGROUND: There are currently few studies regarding late-onset neuromyelitis optica spectrum disorder (LO-NMOSD).
OBJECTIVE: We aimed to describe the characteristic features of patients with LO-NMOSD in Korea.
METHODS: Anti-aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder (NMOSD) from nine tertiary hospitals were reviewed retrospectively. The patients were divided into two groups based on age of onset: LO-NMOSD (⩾50 years of age at onset) versus early-onset neuromyelitis optica spectrum disorder (EO-NMOSD) (<50 years of age at onset). Clinical, laboratory, and magnetic resonance imaging (MRI) parameters were investigated.
RESULTS: Among a total of 147 patients (125 female; age of onset, 39.4 ± 15.2 years), 45 patients (30.6%) had an age of onset of more than 50 years. Compared to patients with EO-NMOSD, patients with LO-NMOSD had more frequent isolated spinal cord involvement at onset (64.4% vs 37.2%, p = 0.002), less frequent involvement of the optic nerve (40.0% vs 67.7%, p = 0.002), and less frequent brain MRI lesions (31.1% vs 50.0%, p = 0.034). Furthermore, there was a significant positive correlation between age of onset and Expanded Disability Status Scale (EDSS) score at last follow-up ( r = 0.246, p = 0.003).
CONCLUSION: Age of onset could be an important predictor of lesion location and clinical course of patients with NMOSD.

Entities:  

Keywords:  Neuromyelitis optica (NMO); age of onset; late-onset neuromyelitis optica; neuromyelitis optica spectrum disorder (NMOSD); seropositive neuromyelitis optica spectrum disorder

Mesh:

Substances:

Year:  2017        PMID: 28058965     DOI: 10.1177/1352458516685416

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  15 in total

Review 1.  [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification].

Authors:  Orhan Aktas; Tania Kümpfel
Journal:  Nervenarzt       Date:  2021-03-16       Impact factor: 1.214

2.  Racial differences in neuromyelitis optica spectrum disorder.

Authors:  Su-Hyun Kim; Maureen A Mealy; Michael Levy; Felix Schmidt; Klemens Ruprecht; Friedemann Paul; Marius Ringelstein; Orhan Aktas; Hans-Peter Hartung; Nasrin Asgari; Jessica Li Tsz-Ching; Sasitorn Siritho; Naraporn Prayoonwiwat; Hyun-June Shin; Jae-Won Hyun; Mira Han; Maria Isabel Leite; Jacqueline Palace; Ho Jin Kim
Journal:  Neurology       Date:  2018-10-26       Impact factor: 9.910

3.  Two cases of late-onset neuromyelitis optica spectrum disorder initially presenting with isolated cerebral white matter lesions.

Authors:  Tai Otani; Takashi Irioka; Yuko K Takahashi; Kazumasa Soga; Susumu Igarashi; Kimihiko Kaneko; Toshiyuki Takahashi; Takanori Yokota
Journal:  eNeurologicalSci       Date:  2018-11-19

4.  The pathologic and diagnostic in magnetic resonance imaging of brain and cervical spine of patients with neuromyelitis optica spectrum disorder.

Authors:  Roshanak Mehdipour-Dastjerdi; Fereshteh Ashtari; Vahid Shaygannejad; Marjan Mansourian; Ali Safaei
Journal:  Iran J Neurol       Date:  2018-04-04

5.  Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Authors:  Jacqueline Palace; Dan-Yu Lin; Donglin Zeng; Masoud Majed; Liene Elsone; Shahd Hamid; Silvia Messina; Tatsuro Misu; Jessica Sagen; Daniel Whittam; Yoshiki Takai; Maria Isabel Leite; Brian Weinshenker; Philippe Cabre; Anu Jacob; Ichiro Nakashima; Kazuo Fujihara; Sean J Pittock
Journal:  Brain       Date:  2019-05-01       Impact factor: 13.501

6.  Late Onset of Neuromyelitis Optica Spectrum Disorders.

Authors:  Yara Dadalti Fragoso; Heloisa Helena Ruocco; Ronaldo Maciel Dias; Hideraldo Cabeça; Ricardo Gonçalves; Nise A de Carvalho Sousa; Caroline Vieira Spessotto; Carlos Bernardo Tauil; Soniza Vieira Alves-Leon; Sidney Gomes; Marcus Vinicius M Gonçalves; Suzana C Nunes Machado; Andrea Anacleto; Eber Castro Correa; Maria Lucia V Pimentel; Gutemberg Augusto C Santos
Journal:  Neurol Ther       Date:  2019-07-02

7.  Short segment myelitis as the initial and only manifestation of aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorders.

Authors:  Wei Fang; Yang Zheng; Fan Yang; Meng-Ting Cai; Chun-Hong Shen; Zhi-Rong Liu; Yin-Xi Zhang; Mei-Ping Ding
Journal:  Ther Adv Neurol Disord       Date:  2020-01-20       Impact factor: 6.570

8.  Predictive Factors of Resistance to High-Dose Steroids Therapy in Acute Attacks of Neuromyelitis Optica Spectrum Disorder.

Authors:  Chuan Qin; Ran Tao; Shuo-Qi Zhang; Bo Chen; Man Chen; Hai-Han Yu; Yun-Hui Chu; Ke Shang; Long-Jun Wu; Bi-Tao Bu; Dai-Shi Tian
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

9.  Comparison of Early- and Late-Onset NMOSD-Related Optic Neuritis in Thai Patients: Clinical Characteristics and Long-Term Visual Outcomes.

Authors:  Watcharaporn Thongmee; Chanomporn Narongkhananukul; Tanyatuth Padungkiatsagul; Panitha Jindahra; Kavin Vanikieti
Journal:  Clin Ophthalmol       Date:  2021-02-04

10.  Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.

Authors:  Maria Sepulveda; Guillermo Delgado-García; Yolanda Blanco; Nuria Sola-Valls; Elena H Martinez-Lapiscina; Thaís Armangué; Carmen Montejo; Irene Pulido-Valdeolivas; Eugenia Martinez-Hernandez; Helena Ariño; Domingo Escudero; Raquel Ruiz-García; Sara Llufriu; Josep Dalmau; Francesc Graus; Albert Saiz
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.